Old Web
English
Sign In
Acemap
>
authorDetail
>
R.E. Ooijevaar
R.E. Ooijevaar
VU University Medical Center
Medicine
Metronidazole
Bezlotoxumab
Vancomycin
Fidaxomicin
4
Papers
138
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review
2021
Clinical Microbiology and Infection
Tessel M. van Rossen
R.E. Ooijevaar
Christina M. J. E. Vandenbroucke-Grauls
Olaf M. Dekkers
Ed J. Kuijper
Josbert J. Keller
Joffrey van Prehn
Show All
Source
Cite
Save
Citations (0)
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
2021
Clinical Microbiology and Infection
J. van Prehn
Elena Reigadas
Erik H. Vogelzang
Emilio Bouza
A. Hristea
Benoit Guery
Marcela Krutova
Torbjörn Norén
Franz Allerberger
J. E. Coia
Abraham Goorhuis
T.M. van Rossen
R.E. Ooijevaar
K. Burns
B.R. Scharvik Olesen
Sarah Tschudin-Sutter
Mark H. Wilcox
Maria J.G.T. Vehreschild
Fidelma Fitzpatrick
E. J. Kuijper
Show All
Source
Cite
Save
Citations (0)
Clinical Application and Potential of Fecal Microbiota Transplantation
2019
Annual Review of Medicine
R.E. Ooijevaar
Elisabeth M. Terveer
Hein W. Verspaget
Ed J. Kuijper
Josbert J. Keller
Show All
Source
Cite
Save
Citations (65)
Update of treatment algorithms for Clostridium difficile infection
2018
Clinical Microbiology and Infection
R.E. Ooijevaar
Y.H. van Beurden
Elisabeth M. Terveer
Abraham Goorhuis
Martijn P. Bauer
Josbert J. Keller
Chris J. Mulder
Ed J. Kuijper
Show All
Source
Cite
Save
Citations (73)
1